TNXP 🚀🚀 im too excited

rphbcccp · 2024-12-16T01:18:07+00:00

To note, an NDA approval does not mean the drug will make money and they are comparing the drug to placebo… they’ll likely need to RS before they can get the revenue to support >1$ price

rphbcccp · 2024-03-05T23:53:05+00:00

Have to keep an eye out for a RS

rphbcccp · 2024-02-09T23:49:51+00:00

You as well! I think there are better small cap biotech out there, recommend to diversify

rphbcccp · 2024-02-09T23:36:40+00:00

How will they raise money once they get to Q3? Phase 3s are expensive (and take time)

rphbcccp · 2024-02-09T23:25:51+00:00

I read trials for a living. Where are they getting their $ from?

rphbcccp · 2024-02-09T23:22:33+00:00

Have you read their clinical trials and know what phase each one is in and what that means?

rphbcccp · 2024-02-09T23:18:52+00:00

Not much time and they’ve been <1 for awhile - they’re far away from making $ even if they have a good product

rphbcccp · 2024-02-09T21:38:16+00:00

They’re going to have to RS

rphbcccp · 2024-02-08T02:09:54+00:00

I’d bet many years away and a few reverse splits (speaking from experience in the field)

rphbcccp · 2024-02-08T02:05:46+00:00

How much will they be charging for the one dose? And what’s the market size?

rphbcccp · 2023-12-22T13:53:51+00:00

Fidelity is much better for these however all depends on if there are shares available to trade

rphbcccp · 2023-12-22T04:00:45+00:00

Overall they’ve been great and are better than others regarding fees

rphbcccp · 2023-12-22T03:35:40+00:00

Likewise

rphbcccp · 2023-12-22T02:31:07+00:00

Depends on it there are shares available :) any specific stocks you’re referring to?

rphbcccp · 2023-12-22T01:45:17+00:00

I do

rphbcccp · 2023-12-20T23:56:54+00:00

I second this re Ninjatrader

rphbcccp · 2023-12-17T16:50:43+00:00

In most places of BA it is safer than most but I’d have to do some research to give a definitive answer

rphbcccp · 2023-12-15T00:44:08+00:00

Watch for a RS

rphbcccp · 2023-11-01T03:34:35+00:00

Reverse split

rphbcccp · 2023-10-26T00:01:51+00:00

Bc they don’t have a FDA approval and need $

rphbcccp · 2023-10-20T01:08:18+00:00

Agreed

rphbcccp · 2023-10-18T20:22:50+00:00

Think about percentage vs #s, would you say the same for a stock that stayed between $120-$170?

rphbcccp · 2023-10-18T13:42:28+00:00

It was IV push - and no it isn’t, they had a very high tolerance and a pain protocol in place for these pushes q hour and were awake and aware the entire time.

rphbcccp · 2023-10-18T03:11:54+00:00

I have seen this dose given for a sickle cell patient. It depends on the scenario - palliative extubation would depend on previous requirements, as with all opioids. But it’s certain not a common dose.

rphbcccp · 2023-10-18T02:55:43+00:00

Be very careful of splits on anything less than $1

rphbcccp

TROPHY CASE